Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Bile Duct Neoplasms (Phase 1)
Biliary Tract Neoplasms (Phase 2)
Carcinoma, Hepatocellular (Phase 1/Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 1)
Carcinoma, Squamous Cell (Phase 1)
Carcinosarcoma (Phase 2)
Cholangiocarcinoma (Phase 1)
Colorectal Neoplasms (Phase 2)
Endometrial Neoplasms (Phase 2)
Esophageal Neoplasms (Phase 2)
Gallbladder Neoplasms (Phase 1)
Multiple Myeloma (Phase 1)
Neoplasms (Phase 1)
Ovarian Neoplasms (Phase 2)
Prostatic Neoplasms (Phase 1/Phase 2)
Stomach Neoplasms (Phase 2)
Uterine Neoplasms (Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue